NSC population and proliferation decrease drastically during the second postnatal week of DG development. حسب Cristina Medina-Menéndez (21800157)

<b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>" حسب Kira Shaw (18796168)

"…<p dir="ltr">The CSV file 'Eyreetal_DrainingVein_SourceData' contains the averaged time series traces and extracted metrics from individual experiments used across Figures 1-5 in the manuscript "Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins". …"

Mean and standard error of sensory properties. حسب Tomoe Hayakawa (20978784)

الموضوعات:

Decreased <i>Notch3</i> asymmetry in <i>Nodal</i> mutants. حسب Tobias Holm Bønnelykke (20968460)

ECoG timescales decrease during spatial attention. حسب Isabel Raposo (21615517)

"…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …"

Mean and standard error of pupil diameter in the dim states. حسب Tomoe Hayakawa (20978784)

الموضوعات:

The linearly decreasing convergence factor a. حسب Junhao Wei (6816803)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. حسب Shuhuan Zhang (748003)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. حسب Zahra Hosseininia (22265113)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. حسب Penghui Hu (695020)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Frequency Chart for optimal maxima case (Frequency = 1.714) (a), second optimal maxima case (Frequency = 1.692) (b), optimal minima case (Frequency = 0.946) (c) and second optimal... حسب Muhammad Hammad Bucha (21736111)

Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces. حسب Lena Thiessen (17605194)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). حسب Murat Tutar (22250461)

الموضوعات:

Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). حسب Murat Tutar (22250461)

الموضوعات: